NDC 70518-3844
buprenorphine hydrochloride and naloxone hydrochloride dihydrate 2 mg / 8 mg tablet
On the label: Remedyrepack Inc.. It's repackaged: Remedyrepack Inc. rebottles it from Hikma Pharmaceuticals USA Inc.'s NDC 0054-0189.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| West-Ward Columbus Inc. | Columbus, OH, United States | Makes it | No problems foundApr 30, 2026 · 27 inspections |
Product details
- Generic drug
- Buprenorphine and Naloxone: every company that makes it
- Form
- tablet, sublingual
- Strength
- 2 mg / 8 mg
- Approval
- ANDA ANDA203326
- On the market since
- Aug 29, 2023
- Package NDCs
70518-3844-0- Official label
- DailyMed (National Library of Medicine), updated Aug 17, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?